Antigen‐specific active immunotherapy for ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antigen‐specific Active Immunotherapy for Ovarian Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437397/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis_New. Accessed 28 March 2024.
Antigen‐specific active immunotherapy for ovarian cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437397/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis_New. Accessed March 28, 2024.
Antigen‐specific active immunotherapy for ovarian cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437397/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis_New
Antigen‐specific Active Immunotherapy for Ovarian Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437397/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antigen‐specific active immunotherapy for ovarian cancer
ID - 437397
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437397/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis_New
DB - Evidence Central
DP - Unbound Medicine
ER -